Quantcast

Posts related to ‘POTP’

Unusual Biotech Movers (DSCO, GNTA, IDMI, DDSS, POTP, DARA)

Discovery Laboratories Inc. (NASDAQ: DSCO) shares are up after a report that their drug Surfaxin, a respiratory distress syndrome treatment for premature infants, should gain FDA approval by May. In ...
Read Full Story »

The 52-Week Low Club

Point Therapeutics (POTP) Delisting sends shares even lower. Down to $.03 from 52-week high of $1.79.Applied Digital Solutions (ADSX) More fall-out from rumors about microchips at sub VeriChip. Down to ...
Read Full Story »

The 52-Week Low Club

Westwood One (WON) CEO at radio company leaving. Down to $5.83 from 52-week high of $8.46.American Home Mtg  (AHM) Dragged down more by real estate market. Down to $14.01 from ...
Read Full Story »